top of page

NEWS & VIEWS

News: News

LETTER TO MINSTER OF HEALTH: CANADA'S BREAST IMPLANT REGISTRY SHOULD BE OPT-OUT, NOT OPT IN
October 2, 2026

GUIDE FOR PATIENTS AND PRESCRIBERS: OBTAINING HYPURIN PORCINE INSULIN IN CANADA THROUGH THE SPECIAL ACCESS PROGRAM
October 2026

SUBMISSION TO STANDING COMMITTEE ON HEALTH (HESA): PHARMACEUTICAL SOVEREIGNTY AND INSULIN SUPPLY IN CANADA
March 13, 2026

LETTER TO MINISTERS OF HEALTH AND INDUSTRY: CANADA NEEDS A DOMESTIC MANUFACTURER OF INSULIN
October 20, 2025

IVSED IS INCORPORATED!
February 14, 2025

BLOG POST: NEW ALZHEIMER DRUGS, BUT SAME OLD HYPE?

August 6, 2023

IVSED IN THE NEWS: BOARD MEMBER OF FEDERAL DRUG-PRICING AGENCY RESIGNS OVER CONCERNS ABOUT PANEL’S INDEPENDENCE

February 23, 2023

February 14, 2023

IVSED IN THE NEWS - POLITICO OTTAWA PLAYBOOK: FOR YOUR RADAR - PMPRB WATCH

December 20, 2022

PRESS RELEASE: PHARMACEUTICAL INVESTOR THOMAS DIGBY IS THE WRONG PERSON TO HEAD CANADA’S DRUG PRICE CONTROL AGENCY

LETTER TO HEALTH MINISTER DUCLOS: SUMMARY OF DEC. 2, 2021 MEETING (ATTACHMENT: PRESCRIRE INTERNATIONAL MAY 2017)

December 13, 2021

IVSED IN THE NEWS - HILL TIMES RESEARCH: COUNTDOWN IN ON AS STAKEHOLDERS WONDER IF NEW PMPRB RULES WILL COME INTO PLAY ON JAN. 1

December 9, 2021

December 8, 2022

IVSED: SUBMISSION TO PMPRB CONSULTATION ON NEW DRAFT GUIDELINES

December 5, 2022

PRESS RELEASE: IVSED CALLS FOR STRONGER REGULATIONS TO PROTECT CANADIANS AGAINST EXCESSIVE DRUG PRICES

PRESS RELEASE: IVSED CALLS ON HEALTH CANADA TO STRENGTHEN TRANSPARENCY, SAFETY AND AFFORDABILITY OF CANADA’S MEDICINES AND TO IMPLEMENT PHARMACARE

November 2, 2021

LETTER TO HEALTH CANADA: CONCERNS REGARDING ALZHEIMER DRUG ADUHELM (FRENCH VERSION)

September 23, 2021

IVSED RESPONSE TO PMPRB PROPOSED GUIDELINES

April 24, 2020

LETTER TO PM TRUDEAU: CHANGES TO PMPRB NEEDED

May 10, 2019

bottom of page